Supplements and Thyroid Medication: What Blocks Absorption

Levothyroxine (brand names include Synthroid, Tirosint, and Levoxyl) is one of the ten most prescribed medications in the United States, taken by roughly 22 million Americans for hypothyroidism. It is also one of the drugs with the most documented interactions with dietary supplements — not because it causes dangerous pharmacological effects in combination, but because its absorption is remarkably sensitive to coadministered substances. Interfering with levothyroxine absorption is equivalent to reducing the dose, which leaves hypothyroidism undertreated: higher TSH, fatigue, weight gain, cognitive fog, and — in severe cases — cardiovascular complications including elevated LDL and increased arterial stiffness.

The mechanism underlying most of these interactions is straightforward: levothyroxine (T4) is a charged molecule that is absorbed primarily in the small intestine through a passive pH-dependent process. Polyvalent cations (calcium, iron, magnesium, aluminum) chelate T4, forming insoluble complexes that pass through the gut unabsorbed. Fiber supplements and resins reduce absorption by binding T4 in the intestinal lumen. These are not subtle interactions — some reduce levothyroxine absorption by 30–40%.

The Key Supplements That Reduce Absorption

Calcium supplements — This is the most clinically important interaction, given how commonly both are taken. Calcium carbonate and calcium citrate reduce levothyroxine absorption. A 1994 crossover study in nine hypothyroid patients found that coadministering calcium carbonate with levothyroxine significantly reduced serum T4 and free T4 concentrations and raised TSH — the hormonal signature of undertreatment. Even calcium in multivitamins produces this interaction. The standard clinical recommendation is to separate levothyroxine from calcium by at least 4 hours.

Iron supplements — Ferrous sulfate reduces levothyroxine absorption. An RCT found that taking ferrous sulfate 300 mg with levothyroxine raised TSH significantly within 12 weeks compared to levothyroxine alone. The interaction is dose-dependent. Separate iron from levothyroxine by 4 hours minimum.

Magnesium supplements — Magnesium, particularly in carbonate and hydroxide forms, chelates T4 similarly to calcium. The interaction is less well-documented than calcium or iron but is pharmacologically predicted and supported by pharmacokinetic data. Separate by at least 4 hours.

Fiber supplements (psyllium, glucomannan) — Soluble fiber in the gut lumen binds T4 and reduces absorption. A case series documented TSH elevation in patients who started psyllium supplementation without adjusting levothyroxine. As with the cation interactions, separation by at least 1–2 hours resolves the problem, though 4 hours is a more conservative safety margin.

Soy protein and soy-based products — Soy isoflavones appear to reduce levothyroxine absorption, possibly through direct binding or through alteration of gut transit and pH. Several case reports and one observational study in formula-fed infants found that soy formula significantly increased levothyroxine requirements. Adults who consume soy-based protein supplements, soy milk, or tofu regularly should take levothyroxine consistently in relation to soy intake and monitor TSH more frequently if dietary patterns change.

Walnuts and high-fiber meals — Walnuts are listed in the prescribing information for several levothyroxine products as reducing absorption through a mechanism that is incompletely understood (possibly tannic acid binding). High-fiber meals generally slow gastric emptying and reduce small intestinal T4 absorption.

Supplements That May Alter Thyroid Function Itself

Beyond absorption interactions, some supplements affect thyroid hormone synthesis and conversion, producing effects that persist even when levothyroxine is correctly absorbed.

High-dose iodine — Excess iodine from supplements (particularly kelp products) can trigger the Wolff-Chaikoff effect, transiently suppressing thyroid hormone synthesis, or cause iodine-induced hyperthyroidism (Jod-Basedow phenomenon) in certain glands with areas of functional autonomy. Both effects alter thyroid status and can destabilize previously controlled hypothyroidism or Hashimoto's disease. Kelp supplements with irregular, high iodine content are particularly unpredictable.

Ashwagandha — Ashwagandha (Withania somnifera) has been shown in one small RCT to increase serum T3 and T4 levels in subclinical hypothyroid patients. While this may be beneficial in some contexts, it can interact with levothyroxine by producing additive thyroid hormone elevation. Patients on levothyroxine who begin ashwagandha should monitor TSH more closely.

Selenium — Selenium is required for the enzyme (deiodinase) that converts T4 to the active T3. Selenium deficiency impairs this conversion; deficiency is correctable. Supplementing beyond sufficiency does not further enhance conversion and may have the paradoxical effect of reducing thyroid peroxidase antibodies in Hashimoto's — a finding observed in trials using 200 mcg/day selenomethionine. Patients with Hashimoto's and documented selenium deficiency may benefit from supervised supplementation.

Practical Management

The universal solution for most of these interactions is time separation: take levothyroxine first thing in the morning on an empty stomach, at least 30–60 minutes before eating, and at least 4 hours before any calcium, iron, magnesium, or fiber supplement. Alternatively, Tirosint (levothyroxine in a liquid gel capsule) has better absorption consistency and may be less affected by some interactions. Any change in supplement regimen should be followed by a TSH test in 6–8 weeks. The symptoms of undertreated hypothyroidism develop slowly enough that many patients do not notice them — but the TSH does not lie.